NurseJet
Back to Discover
Systematic ReviewResearchMedication SafetyPatient Education

Kidney disease and higher dose were linked to allopurinol severe skin reactions

Drug safety (PubMed)Sep 15, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic review of observational studies associated chronic kidney disease, female sex, and higher allopurinol dose with severe cutaneous adverse reactions, while substantial heterogeneity and possible publication bias limit certainty.

What NurseJet pulled from the source

Across 26 studies, chronic kidney disease was associated with higher odds of allopurinol-related SCAR (OR 3.78), as was female sex (OR 2.06). Five studies found that cases received doses averaging 19.61 mg higher than tolerant controls, but the evidence does not establish causation or a validated bedside prediction rule.

Why this matters for nurses

Severe cutaneous reactions can progress rapidly. Nurses performing medication reconciliation and follow-up can identify kidney disease, verify the prescribed regimen, teach early symptom reporting, and escalate a new rash or systemic symptoms promptly.

Bedside takeaway

Treat new rash or systemic symptoms during allopurinol therapy as an urgent medication-safety concern.

Key takeaways

  • Chronic kidney disease was associated with allopurinol-induced SCAR across 16 studies involving 1,625 cases and 553,804 controls.
  • Female sex was associated with higher odds across 20 studies, while age and concomitant diuretic use were not significant in the primary meta-analyses.
  • The authors recommend considering non-genetic factors alongside pharmacogenomic screening in future risk-stratification approaches, not using these associations as a stand-alone rule.

Practice implications

  • Confirm that kidney function and the prescribed allopurinol dose have been reviewed under the local medication-safety process. Escalate a new rash or concern for a severe reaction promptly, following facility policy rather than changing therapy independently.

Limitations & cautions

  • Abstract-only summary of observational evidence. The included studies were heterogeneous, publication bias was possible, dose differences were based on five studies, and associations cannot determine individual causation or replace established genetic and clinical assessment.
  • AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Drug safety (PubMed)

Drug safety (PubMed). Non-genetic Risk Factors for Allopurinol-Induced Severe Cutaneous Adverse Reaction (SCAR): A Systematic Review.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42742931/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Family Medicine and Community Health (PubMed)

A dose-response meta-analysis of prospective cohorts found that higher ultra-processed food intake was associated with higher risks of cardiovascular events, cancer, obesity or overweight, metabolic syndrome or diabetes, depression or anxiety, digestive disease, and all-cause mortality.

Med-SurgTelemetryAI summaryReview source

Journal of Clinical Nursing (PubMed)

A mixed-methods systematic review found that nurses viewed situational awareness, teamwork, communication, leadership, experience, intuition, and freedom from retribution as important to recognizing and escalating clinical deterioration.

LeadershipMed-SurgAI summaryReview source

Journal of Advanced Nursing (PubMed)

A systematic review and meta-analysis found moderate-certainty evidence that nurse-led or nurse-coordinated multicomponent nonpharmacologic programs reduced delirium incidence in hospitalized adults aged 60 or older.

GeriatricsMed-SurgAI summaryReview source